PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-89.54%
Both yoy net incomes decline, with CRK at -9.56%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
1.22%
D&A growth of 1.22% while CRK is zero at 0.00%. Bruce Berkowitz would see a mild cost difference that must be justified by expansions.
-27.27%
Negative yoy deferred tax while CRK stands at 2024.15%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
393.72%
Slight usage while CRK is negative at -67.85%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
14.98%
Some yoy usage while CRK is negative at -20.20%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-38.83%
Negative yoy while CRK is 6.79%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
37.95%
Operating cash flow growth at 50-75% of CRK's 67.01%. Martin Whitman would worry about lagging operational liquidity vs. competitor.
-24.36%
Negative yoy CapEx while CRK is 4.02%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
24525.00%
Acquisition growth of 24525.00% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
385.71%
Purchases growth of 385.71% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
24.36%
Liquidation growth of 24.36% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-284.94%
We reduce yoy other investing while CRK is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-194.64%
We reduce yoy invests while CRK stands at 4.02%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
-89.47%
Both yoy lines negative, with CRK at -98.48%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
No Data
No Data available this quarter, please select a different quarter.